Confirmation by Early Oncologic Outcomes After Surgery of the Accuracy of Intermediate-risk Prostate Cancer Classification Based on Magnetic Resonance Imaging Staging and Targeted Biopsy

Over the past decade, prostate cancer (PCa) diagnosis drastically evolved from systematic biopsies (SBs) to multiparametric magnetic resonance imaging (mpMRI) and targeted biopsy (TB), which have emerged as powerful imaging tools for diagnosis, staging, and preoperative planning. MRI and TB should n...

Descripción completa

Detalles Bibliográficos
Autores principales: Manceau, Cécile, Beauval, Jean-Baptiste, Lesourd, Marine, Almeras, Christophe, Gautier, Jean-Romain, Soulié, Michel, Loison, Guillaume, Salin, Ambroise, Tollon, Christophe, Malavaud, Bernard, Roumiguié, Mathieu, Ploussard, Guillaume
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Brief Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317854/
https://www.ncbi.nlm.nih.gov/pubmed/34337461
http://dx.doi.org/10.1016/j.euros.2020.07.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317854/
https://www.ncbi.nlm.nih.gov/pubmed/34337461
http://dx.doi.org/10.1016/j.euros.2020.07.003

Ejemplares similares